Saurabh has always been a fan of Divi’s Lab, the blue-chip Pharma multibagger stock and buys it whenever it is in the doldrums.
“We quadrupled our position in Divi’s Lab in November, December last year,” he disclosed. He also disclosed that he is aggressively buying other API and intermediate companies like Alkyl Amines. “Alkyl Amines remains a large holding for us“….
Saurabh Mukherjea discusses the latest stock picks
| Subscribe To Our Free Newsletter |
